556 related articles for article (PubMed ID: 16774108)
21. Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis.
Mugheddu C; Atzori L; Lappi A; Pau M; Murgia S; Rongioletti F
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e420-e421. PubMed ID: 28319281
[No Abstract] [Full Text] [Related]
22. Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis.
Barland C; Kerdel FA
Arch Dermatol; 2003 Jul; 139(7):949-50. PubMed ID: 12873907
[No Abstract] [Full Text] [Related]
23. Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis.
Reich K; Nestle FO; Wu Y; Bala M; Eisenberg D; Guzzo C; Li S; Dooley LT; Griffiths CE
Eur J Dermatol; 2007; 17(5):381-6. PubMed ID: 17673380
[TBL] [Abstract][Full Text] [Related]
24. Erythrodermic psoriasis and secukinumab: Our clinical experience.
Mateu-Puchades A; Santos-Alarcón S; Martorell-Calatayud A; Pujol-Marco C; Sánchez-Carazo JL
Dermatol Ther; 2018 Jul; 31(4):e12607. PubMed ID: 29663615
[No Abstract] [Full Text] [Related]
25. Acute treatment of generalized pustular psoriasis of von Zumbusch with single-dose infliximab.
Smith N; Harms KL; Hines AC; Harms PW; Gudjonsson JE; Hristov AC; Wang F
J Am Acad Dermatol; 2013 Jun; 68(6):e187-9. PubMed ID: 23680215
[No Abstract] [Full Text] [Related]
26. From biologic to biologic to biologic: lessons to learn for erythrodermic and recalcitrant chronic plaque psoriasis.
Yip L; Harrison S; Foley P
Australas J Dermatol; 2008 Aug; 49(3):152-5. PubMed ID: 18638223
[TBL] [Abstract][Full Text] [Related]
27. Treatment of recalcitrant erythrodermic psoriasis with ustekinumab.
Stinco G; Piccirillo A; Errichetti E; Bergamo S; Patrone P
Eur J Dermatol; 2014; 24(3):387-90. PubMed ID: 24721883
[No Abstract] [Full Text] [Related]
28. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.
Rosenbach M; Hsu S; Korman NJ; Lebwohl MG; Young M; Bebo BF; Van Voorhees AS;
J Am Acad Dermatol; 2010 Apr; 62(4):655-62. PubMed ID: 19665821
[TBL] [Abstract][Full Text] [Related]
29. Psoriasis-induced postoperative cardiac failure.
Jha PK; Das SR; Musleh GS; Lakshmanan S; Kingston TP; Deiraniya AK
Ann Thorac Surg; 2005 Apr; 79(4):1390-1. PubMed ID: 15797087
[TBL] [Abstract][Full Text] [Related]
30. Infliximab: efficacy in psoriasis.
Arsiwala S
Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S25-34. PubMed ID: 23974692
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab.
Yawalkar N; Hunger RE
Dermatology; 2009; 218(1):79-83. PubMed ID: 18974629
[No Abstract] [Full Text] [Related]
32. Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis.
Takahashi MD; Castro LG; Romiti R
Br J Dermatol; 2007 Oct; 157(4):828-31. PubMed ID: 17711530
[No Abstract] [Full Text] [Related]
33. Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients.
Hussain W; Coulson I; Owen C
Clin Exp Dermatol; 2008 Jul; 33(4):520-2. PubMed ID: 18462438
[No Abstract] [Full Text] [Related]
34. Three years' experience with infliximab in recalcitrant psoriasis.
Ahmad K; Rogers S
Clin Exp Dermatol; 2006 Sep; 31(5):630-3. PubMed ID: 16901301
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail.
Buggiani G; D'Erme AM; Krysenka A; Pescitelli L; Lotti T; Prignano F
Dermatol Ther; 2012; 25(3):283-5. PubMed ID: 22913449
[No Abstract] [Full Text] [Related]
36. A systematic review of treatment strategies for erythrodermic psoriasis.
Reynolds KA; Pithadia DJ; Lee EB; Liao W; Wu JJ
J Dermatolog Treat; 2021 Feb; 32(1):49-55. PubMed ID: 31682547
[No Abstract] [Full Text] [Related]
37. Different response rates between palmoplantar involvement and diffuse plaque psoriasis in patients treated with infliximab.
Brunasso AM; Puntoni M; Delfino C; Massone C
Eur J Dermatol; 2012; 22(1):133-5. PubMed ID: 22134100
[No Abstract] [Full Text] [Related]
38. Erythrodermic psoriasis.
Mumoli N; Vitale J; Gambaccini L; Sabatini S; Brondi B; Cei M
QJM; 2014 Apr; 107(4):315. PubMed ID: 23764512
[No Abstract] [Full Text] [Related]
39. Use of infliximab in the treatment of psoriasis.
Lee MR; Cooper AJ
Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904
[No Abstract] [Full Text] [Related]
40. Long-term management of generalized pustular psoriasis with infliximab: case series.
Routhouska SB; Sheth PB; Korman NJ
J Cutan Med Surg; 2008; 12(4):184-8. PubMed ID: 18627699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]